Research Article
MCP-4 and Eotaxin-3 Are Novel Biomarkers for Chronic Obstructive Pulmonary Disease
Figure 5
mRNA levels of MCP-4 and eotaxin-3 were elevated in HBEs treated with LPS. (a, b) Expression of MCP-4 and eotaxin-3 was elevated in HBEs stimulated with LPS. (c–f) LPS-induced increase of MCP-4 and eotaxin-3 mRNAs also exhibited dose- and time-dependent manner. ∗. MCP-4, monocyte chemoattractant protein.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |